Yarrow Bioscience, Inc. (YARW)

NASDAQ: YARW · Real-Time Price · USD

41.52

+0.12 (0.29%)

At close: Aug 18, 2026, 4:00 PM EDT

32.72

-8.80 (-21.20%)

After-hours: Aug 18, 2026, 4:47 PM EDT

Yarrow Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Cash & Equivalents	99.99
Cash & Short-Term Investments	99.99
Cash Growth	-
Prepaid Expenses	0.01
Total Current Assets	100
Long-Term Deferred Charges	0.41
Total Assets	100.41
Accounts Payable	1.53
Accrued Expenses	70.01
Total Current Liabilities	71.55
Total Liabilities	71.55
Additional Paid-In Capital	0
Retained Earnings	-70.99
Total Common Equity	-70.99
Shareholders' Equity	28.86
Total Liabilities & Equity	100.41
Net Cash (Debt)	99.99
Net Cash Growth	-
Net Cash Per Share	23.53
Filing Date Shares Outstanding	4.25
Total Common Shares Outstanding	4.25
Working Capital	28.45
Book Value Per Share	-16.70
Tangible Book Value	-70.99
Tangible Book Value Per Share	-16.70

SEC Filings: 10-K · 10-Q